MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2026 International Congress

    Understanding the Earliest Phases of Parkinson’s disease: An Update on the Prodromal Effort Within the Global Parkinson’s Genetics Program

    M. Tan, S. Meyer, K. Atterling-Brolin, L. Lange, M. Periñan, S. Waters, C. Gabbert, A. Noyce (Oslo, Norway)

    Objective: To continue recruitment of global ‘at-risk’, early and prodromal Parkinson’s disease (PD) cohorts to the Global Parkinson’s Genetics Program (GP2, http://gp2.org/), support existing cohorts…
  • 2026 International Congress

    Olfactory Dysfunction Across Neurodegenerative Disorders: A Prospective Cross-Sectional Comparison of Parkinson’s Disease, Alzheimer’s Disease and Idiopathic REM Sleep Behavior Disorder

    J. Einhaus, E. Kara, H. Jergas, C. Schedlich-Teufer, G. Tamgüney, G. Fink, M. Sommerauer, ö. Onur, M. Barbe (Cologne, Germany)

    Objective: To investigate whether olfactory function as measured by a standardized odor identification (Sniffin’ Stick) test, differs between patients with Parkinson's disease (PD), Alzheimer's disease…
  • 2026 International Congress

    Sex Differences in Prodromal Features of Parkinson’s Disease: Evidence from Large Multi-Centre Cohorts

    M. Tan, Y. Zaplatnikov, K. Atterling-Brolin, S. Jónsdóttir, S. Schnell, R. Krüger, W. Poewe, P. Mahlknecht, E. Tolosa, M. Marti, V. Satagopam, C. Trenkwalder, L. Smith, C. Horlings, A. Noyce (Oslo, Norway)

    Objective: To explore sex differences in symptoms of prodromal Parkinson’s disease (PD) in large, population-based multi-centre cohorts of healthy individuals, PREDICT-PD and Healthy Brain Ageing…
  • 2026 International Congress

    Olfactory Dysfunction in Parkinson’s Disease: A Single-Center Study Using the Alcohol Sniff Test

    S. Marisdina, U. Manurung (Palembang, Indonesia)

    Objective: This study aimed to assess the prevalence of olfactory dysfunction in patients with Parkinson’s disease using the Alcohol Sniff Test in a single-center clinical…
  • 2025 International Congress

    Olfactory-Trigeminal Interactions in Parkinson’s Disease Compared to Other Olfactory Disorders

    S. Brosse, O. Fortier-Lebel, E. Hudon, K. Lapointe, C. Tremblay, J. Frasnelli (Trois-Rivières, Canada)

    Objective: To investigate the interaction between the olfactory and trigeminal systems in Parkinson’s disease (PD) as opposed to other forms of olfactory dysfunction and controls…
  • 2025 International Congress

    Utility of Digital Olfactory Assessment (Sensify) in Parkinson’s Disease: Preliminary Findings from the IPDGC Africa in Egypt

    N. Shebl, S. Mondal, F. Waheed, A. Farag, N. Abonar, M. Abdelhady, S. Asran, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: Validate a digital olfactory assessment for Parkinson’s disease (PD) in Egyptian participants by comparing olfactory performance in PD patients, healthy controls, and those with…
  • 2025 International Congress

    Identifying subjects at high risk for prodromal Parkinson’s Disease using dopamine transporter imaging deficit in a step-wise recruitment strategy: Data of Healthy Brain Ageing (HeBA)

    S. Schade, C. Corinne, S. Ghosh, A. Garrido, E. Lang, P. Mahlknecht, C. Pauly, D. Pilco, R. Rautenkranz, K. Rege, S. Scaglione, S. Schnell, T. Wicke, V. Satagopam, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)

    Objective: To optimize screening for subjects with dopamine transporter (DaT) imaging deficit being at high risk for prodromal Parkinson's disease (PD). Background: Efficient screening methods…
  • 2025 International Congress

    Alpha-Synuclein Aggregates in the Olfactory Epithelium of Subjects with Parkinson Disease, Dementia, COVID-19, and in Aged Controls

    J. Tomlinson, N. Lengacher, A-K. Jochum, J. Franz, L. Flatz, B. Mollenhauer, C. Stadelmann, J. Woulfe, M. Schlossmacher (Ottawa, Canada)

    Objective: We sought to examine whether neuroepithelial structures of the nasal cavity differ between individuals diagnosed with a Lewy body disorder vs those with COVID19…
  • 2025 International Congress

    PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease

    J. Li, K. Grimes, J. Saade, N. Mauri, J. Tomlinson, A. Frank, D. Manuel, B. Mollenhauer, M. Schlossmacher (Ottawa, Canada)

    Objective: To pilot the 2-step PREDIGT Score model for feasibility and improve it by simplifying both steps. Background: We previously demonstrated that the original PREDIGT…
  • 2025 International Congress

    16-years of Evaluations for Prodromal Parkinson Features in an At-Risk Cohort with Gaucher Disease

    E. Sidransky, E. Ryan, S. Nishimura, N. Tayebi, G. Lopez (Bethesda, MD, USA)

    Objective: To evaluate prodromal features of Parkinson disease in a cohort of "at-risk"  Gaucher patients and GBA1 carriers . Background: Variants in GBA1 mutations are…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley